309 related articles for article (PubMed ID: 2191610)
1. [Contribution of immunoenzymatic technics to the assay of anti-native DNA antibodies in the biological diagnosis of lupus erythematosus disseminatus].
Laplanche S; Diemert MC; Musset L; Abuaf N; Galli J
Ann Biol Clin (Paris); 1990; 48(3):177-81. PubMed ID: 2191610
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of indirect immunofluorescence on Crithidia luciliae of Farr test, and immunoenzymatic methods for the screening of anti-native DNA autoantibodies].
Chrétien P; Dauvin M; Hélin P; Ocwieja T; Absalon YB; Johanet C
Ann Biol Clin (Paris); 1994; 52(9):645-50. PubMed ID: 7872513
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
[TBL] [Abstract][Full Text] [Related]
4. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
7. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
[TBL] [Abstract][Full Text] [Related]
8. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
Burdash NM; Teti G; Papadopoulos V
Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus.
Launay D; Schmidt J; Lepers S; Mirault T; Lambert M; Kyndt X; Reumaux D; Duhamel A; Hachulla E; Hatron PY; Prin L; Dubucquoi S
Clin Chim Acta; 2010 Jul; 411(13-14):959-64. PubMed ID: 20303931
[TBL] [Abstract][Full Text] [Related]
10. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test.
Conrad K; Ittenson A; Reinhold D; Fischer R; Roggenbuck D; Büttner T; Bosselmann HP; Steinbach J; Schössler W
Ann N Y Acad Sci; 2009 Sep; 1173():180-5. PubMed ID: 19758148
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
Whitehouse IJ; Fehr K; Wagenhäuser FJ
Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
[TBL] [Abstract][Full Text] [Related]
12. [The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases].
Sinico RA; Radice A
G Ital Nefrol; 2005; 22 Suppl 33():S21-6. PubMed ID: 16419001
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test.
Werle E; Blazek M; Fiehn W
Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405
[TBL] [Abstract][Full Text] [Related]
14. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
[TBL] [Abstract][Full Text] [Related]
15. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an ELISA method for the measurement of antibodies to dsDNA.
Mohan TC; Jalil HA; Nadarajah M; Sng EH
Singapore Med J; 1989 Jun; 30(3):242-5. PubMed ID: 2686035
[TBL] [Abstract][Full Text] [Related]
17. A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies.
Radice A; Sinico RA
Autoimmunity; 2006 Mar; 39(2):113-9. PubMed ID: 16698667
[TBL] [Abstract][Full Text] [Related]
18. Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA.
Henderson T; Medsger TA; Sontheimer RD; Harmon CE; Deng JS
Diagn Clin Immunol; 1987; 5(1):20-4. PubMed ID: 3297382
[TBL] [Abstract][Full Text] [Related]
19. Direct evaluation of class-specific anti-DNA antibodies by an immunoenzymatic technique.
Labrousse H; Tron F; Avrameas S; Bach JF
J Clin Lab Immunol; 1980 May; 3(3):191-5. PubMed ID: 6999157
[TBL] [Abstract][Full Text] [Related]
20. The significance of discrepant Farr and Crithidia luciliae tests.
McGuigan L; Edmonds J; Wellings G; Jones M
J Rheumatol; 1984 Apr; 11(2):172-4. PubMed ID: 6610050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
